Navigation Links
Transition Therapeutics Announces Second Quarter Fiscal 2009 Financial Results
Date:2/11/2009

>

Amortization

Amortization for the three-month period ended December 31, 2008, increased $27,262 to $691,168 as compared to $663,906 for the three-month period ended December 31, 2007. For the six-month period ended December 31, 2008, amortization increased $159,173 to $1,482,397 as compared to $1,323,224 for the same period in fiscal 2008.

The three-month period increase in amortization expense is primarily due to the amortization expense relating to the compounds, technology and patents acquired from Forbes during the first quarter of fiscal 2009. The six-month period increase in amortization expense is due to increased amortization expense relating to the workforce acquired from Protana due to a workforce reduction, the full-quarter impact of amortizing the additional consideration paid to acquire the ENI technology in December, 2007 and the amortization expense resulting from the assets acquired from Forbes.

Interest Income, net

Interest income for the three-month period ended December 31, 2008 was $346,505 as compared to $692,552 for the same period in fiscal 2008, resulting in a decrease of $346,047. For the six-month period ended December 31, 2008, interest income was $760,129 as compared to $1,289,031 for the same period in fiscal 2007, resulting in a decrease of $528,902. The decreases in interest income resulted from decreased cash balances due to cash disbursements as well as decreases in effective interest rates.

    About Transition
    ----------------

Transition is a biopharmaceutical company, developing novel therapeutics for disease indications with large markets. Transition's lead products include ELND005 (AZD-103) for the treatment of Alzheimer's disease and TT-223 for the treatment of diabetes. Transition has an emerging pipeline of preclinical drug candidates acquired externally or developed internally using its proprietary drug discove
'/>"/>

SOURCE Transition Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. Transition Therapeutics Announces Fiscal 2007 Year End Financial Results
2. Transition Therapeutics Receives Remaining Upfront Payment from Elan Corporation, plc
3. Transition Therapeutics to Hold Conference Call on First Quarter Fiscal 2008 Financial Results on Wednesday, November 14, at 8:30 A.M. EST
4. New UIC center to study end-of-life transition
5. Seabrook House Opens Transitional Living Facility: Seabrook West
6. Transition Therapeutics Announces Milestone Payment from Elan
7. Transition Therapeutics Announces Appointment of Vice-President of Business Development
8. Pure Weight Loss Takes Additional Steps To Assure Seamless Transition For Clients
9. Zimmer Spine Introduces New Rigid to Dynamic Stabilization Transition System
10. Bisexuality not a transitional phase among women, according to new research
11. Transition of Behavioral Health Services from WPIC-BV to Heritage Valley Health System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... Regenerative Medicine Solutions (RMS) is set ... Nashville, Tennessee. RMS welcomes the launch of an entirely ... of a new treatment center for the Lung Institute. ... Institute to Nashville, the hope is to bring awareness ... diagnosed and undiagnosed. With Nashville being a hub for ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Two revolutionary procedures ... treatment of gum disease a far less painful ... past. , “If you’ve ever felt electric shock waves surge ... sip a cold beverage, it’s possible you already know the ... who is a general dentist in West Palm Beach, and ...
(Date:9/30/2014)... (Sept. 30, 2014) Levothyroxine is considered the gold ... a new review of therapies for the condition ... altered that assessment, say a team of investigators.,1Their analysis, ... Thyroid , finds insufficient consistent data exist to ... generic, or sold under various trade names, such as ...
(Date:9/30/2014)... ANN ARBORThe discovery of a gene mutation that causes ... development of drugs that block the rapid, unstoppable cell ... at the University of Michigan and the U-M Health ... devastating disease dyskeratosis congenita, in which precious hematopoietic stem ... DC age prematurely and are prone to cancer and ...
(Date:9/30/2014)... Cleveland, Ohio (PRWEB) September 30, 2014 ... agreement which provides CHL access to Life Length’s proprietary ... most advanced and comprehensive telomere test on the market ... that reports the percentage of short telomeres, providing the ... Shay, Vice Chairman of the Department of Cell Biology ...
Breaking Medicine News(10 mins):Health News:Regenerative Medicine Solutions Expanding 2Health News:Florida Dentist Battles Gum Disease With Latest Techniques 2Health News:Florida Dentist Battles Gum Disease With Latest Techniques 3Health News:New guidelines for treatment of hypothyroidism endorse current therapy 2Health News:Disease decoded: Gene mutation may lead to development of new cancer drugs 2Health News:Life Length® Announces New Partnership with Cleveland HeartLab® to Offer Telomere Technology in North America 2Health News:Life Length® Announces New Partnership with Cleveland HeartLab® to Offer Telomere Technology in North America 3
... for treating age-related loss of strength, researchers say , ... exercised and received the growth hormone known as "mechano ... to a British study. , The results suggest that ... which causes increased fragility, said Dr. Geoff Goldspink of ...
... of psychiatric side effects, including suicidal thoughts, , WEDNESDAY, ... help people quit smoking, Chantix and Zyban, will now ... problems, including depression and suicidal thoughts, U.S. health officials ... Administration said it was mandating the black-box warnings, the ...
... ... of the journal Nature includes three companion papers describing the results of ... psychiatric disorder that affects up to 70 million people worldwide. The causes ... some individuals the current treatments work well. There are multiple factors that ...
... 1 Despite rapid advances using a child,s own cord ... due to injury or disease, most pregnant women today don,t ... According to research published in the Journal of Reproductive ... themselves only "minimally informed." , , (Logo: ...
... , OAKBROOK TERRACE, Ill., July 1 Dental Network ... its acquisition of DenteMax, an independent subsidiary of Blue ... providing and administering health benefits to members residing in ... reside outside the state. , , ...
... Give BCBSM Customers Expanded National Dental Network; Solidify BCBSM Position ... Mich., July 1 Blue Cross Blue Shield of Michigan ... been acquired by Dental Network of America, LLC (DNoA), a ... BCBSM and DNoA -- will provide BCBSM with a more ...
Cached Medicine News:Health News:Growth Hormone May Build Muscle in Older Men 2Health News:Anti-Smoking Drugs Get FDA 'Black-Box' Warning 2Health News:Anti-Smoking Drugs Get FDA 'Black-Box' Warning 3Health News:International Collaboration led by Dr. Pablo V. Gejman,Researcher At NorthShore University HealthSystem's Research Institute, Finds Genetic Association of Schizophrenia to Chromosome 6p Variant 2Health News:International Collaboration led by Dr. Pablo V. Gejman,Researcher At NorthShore University HealthSystem's Research Institute, Finds Genetic Association of Schizophrenia to Chromosome 6p Variant 3Health News:International Collaboration led by Dr. Pablo V. Gejman,Researcher At NorthShore University HealthSystem's Research Institute, Finds Genetic Association of Schizophrenia to Chromosome 6p Variant 4Health News:Cord Blood Awareness Month: Understanding Still Low, Despite Medical Advancements 2Health News:Cord Blood Awareness Month: Understanding Still Low, Despite Medical Advancements 3Health News:Cord Blood Awareness Month: Understanding Still Low, Despite Medical Advancements 4Health News:Dental Network of America (DNoA) Acquires DenteMax, Owned by Blue Cross Blue Shield of Michigan 2Health News:Dental Network of America (DNoA) Acquires DenteMax, Owned by Blue Cross Blue Shield of Michigan 3Health News:Dental Network of America (DNoA) Acquires DenteMax, Owned by Blue Cross Blue Shield of Michigan 4Health News:Blue Cross Blue Shield of Michigan-owned DenteMax Acquired by Dental Network of America 2Health News:Blue Cross Blue Shield of Michigan-owned DenteMax Acquired by Dental Network of America 3Health News:Blue Cross Blue Shield of Michigan-owned DenteMax Acquired by Dental Network of America 4Health News:Blue Cross Blue Shield of Michigan-owned DenteMax Acquired by Dental Network of America 5
(Date:9/30/2014)... , Sept. 30, 2014 BioStructures, ... the American Association of Tissue Banks (AATB), it ... Chief Executive Officer. Accreditation follows an ... a specially trained AATB inspector.  It establishes that ... within the facility meets or exceeds the standards ...
(Date:9/30/2014)...  Proteomics is a focus point for investment ... Kalorama Information.  The healthcare market research publisher said that ... the past two years.  The activity ranges from ... companies and academic institutions, to deals between pharma ... Kalorama observed the industry in its report, ...
(Date:9/30/2014)... -- In a recent study it was ... the Eldor spinal needle 25G, 103 mm appeared significantly ... spinal needles of the same gauge and length of ... an excellent type of regional anesthesia for many operations ... It is estimated that 100 million patients worldwide ...
Breaking Medicine Technology:Biostructures, LLC Earns AATB Accreditation 2Report: Race for Proteomics Knowledge Spurs Investment and Partnerships 2Report: Race for Proteomics Knowledge Spurs Investment and Partnerships 3
...  Results from the combined analysis of two European ... 3rd European Lung Cancer Conference in Geneva, Switzerland. ... samples from advanced non-squamous non-small cell lung cancer ... plus erlotinib.  Results showed that the VeriStrat test ...
... (NASDAQ: STAA ), the leading developer, manufacturer and ... that the total number of its Visian® ICL implants in ... have been the Visian Toric ICL which is approved in ... of the U.S. The Company will highlight the benefits of ...
Cached Medicine Technology:VeriStrat® Test Results Correlate with Survival Outcomes in Advanced Lung Cancer 2VeriStrat® Test Results Correlate with Survival Outcomes in Advanced Lung Cancer 3STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress 2STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress 3STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress 4STAAR Surgical Celebrates Over 300,000 Successful Visian® ICL Implants at ASCRS Congress 5
Used for traversing and exploring urethral strictures. The malleable tip can be shaped to desired configuration. The proximal end is threaded to attach to standard followers. Supplied sterile in peel...
Used to dilate the male or female urethra to treat stricture disease. Supplied sterile in peel-open packages. Intended for one-time use....
The balloon catheter is designed to pass over a previously placed .015 inch diameter wire guide included. Supplied sterile in peel-open packages. Intended for one-time use....
Radiopaque markers are placed at the proximal and distal ends of the balloon. A special pin vise handle is included to stabilize the wire guide during introduction. Supplied sterile in peel-open pack...
Medicine Products: